Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Phenylpropanoids of Plant Origin as Inhibitors of Biofilm Formation by Candida albicans

  • Received : 2014.02.25
  • Accepted : 2014.05.22
  • Published : 2014.09.28
Download PDF
⟨ Previous Next ⟩

Abstract

Biofilm-related infections of Candida albicans are a frequent cause of morbidity and mortality in hospitalized patients, especially those with immunocompromised status. Options of the antifungal drugs available for successful treatment of drug-resistant biofilms are very few, and as such, new strategies need to be explored against them. The aim of this study was to evaluate the efficacy of phenylpropanoids of plant origin against planktonic cells, important virulence factors, and biofilm forms of C. albicans. Standard susceptibility testing protocol was used to evaluate the activities of 13 phenylpropanoids against planktonic growth. Their effects on adhesion and yeast-to-hyphae morphogenesis were studied in microplate-based methodologies. An in vitro biofilm model analyzed the phenylpropanoid-mediated prevention of biofilm development and mature biofilms using XTT-metabolic assay, crystal violet assay, and light microscopy. Six molecules exhibited fungistatic activity at ${\leq}0.5mg/ml$, of which four were fungicidal at low concentrations. Seven phenylpropanoids inhibited yeast-to-hyphae transition at low concentrations (0.031-0.5 mg/ml), whereas adhesion to the solid substrate was prevented in the range of 0.5-2 mg/ml. Treatment with ${\leq}0.5mg/ml$ concentrations of at least six small molecules resulted in significant (p < 0.05) inhibition of biofilm formation by C. albicans. Mature biofilms that are highly resistant to antifungal drugs were susceptible to low concentrations of 4 of the 13 molecules. This study revealed phenylpropanoids of plant origin as promising candidates to devise preventive strategies against drug-resistant biofilms of C. albicans.

Keywords

References

  1. Betts JW, Haswell SJ. 2013. Antifungal synergy of theaflavin and epicatechin combinations against Candida albicans. J. Microbiol. Biotechnol. 23: 1322-1326. https://doi.org/10.4014/jmb.1303.03010
  2. Bink A, Pellens K, Cammue BPA, Thevissen K. 2011. Antibiofilm strategies: how to eradicate Candida biofilms? Open Mycol. J. 5: 29-38. https://doi.org/10.2174/1874437001105010029
  3. Camacho DP, Gasparetto A, Svidzinski TIE. 2007. The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters. Mycopathologia 163: 261-266 https://doi.org/10.1007/s11046-007-9007-x
  4. Campbell BC, Chan KL, Kim JH. 2013. Chemosensitization as a means to augment commercial antifungal agents. Front. Microbiol. 3.
  5. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormic T, Ghannoum MA. 2001. Biofilm formation by fungal pathogen Candida albicans: development, architecture and drug resistance. J. Bacteriol. 183: 5385-5394. https://doi.org/10.1128/JB.183.18.5385-5394.2001
  6. Chauhan NM, Raut JS, Karuppayil SM. 2011. Acetaldehyde inhibits yeast to hyphal form morphogenesis and biofilm formation in Candida albicans. Mycoscience 52: 356-360. https://doi.org/10.1007/S10267-011-0110-Y
  7. Clatworthy AE, Pierson E, Hung DT. 2007. Targeting virulence: a new paradigm for antimicrobial therapy. Nature Chem. Biol. 3: 541-548. https://doi.org/10.1038/nchembio.2007.24
  8. Clifford MN. 1999. Chlorogenic acids and other cinnamates- nature, occurrence and dietary burden. J. Sci. Food Agric. 9: 362-372.
  9. Clinical and Laboratory Standards Institute (CLSI). 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard, 2nd Ed. M27-A2. Wayne, PA.
  10. Cuellar-Cruz M, Vega-Gonzalez A, Mendoza-Novelo B, Lopez-Romero E, Ruiz-Baca E, Quintanar-Escorza MA, et al. 2012. The effect of biomaterials and antifungals on biofilm formation by Candida species: a review. Eur. J. Clin. Microbiol. Infect Dis. 31: 2513-2527. https://doi.org/10.1007/s10096-012-1634-6
  11. Darvishi E, Omidi M, Bushehri AAS, Golshani A, Smith ML. 2013. The antifungal eugenol perturbs dual aromatic and branched-chain amino acid permeases in the cytoplasmic membrane of yeast. PLoS One 8: e76028. https://doi.org/10.1371/journal.pone.0076028
  12. De Vita D, Friggeri L, D'Auria FD, Pandolfi F, Piccoli F, Panella S, et al. 2014. Activity of caffeic acid derivatives against Candida albicans biofilm. Bioorg. Med. Chem. Lett. 24: 1502-1505. https://doi.org/10.1016/j.bmcl.2014.02.005
  13. Ergun BC, Coban T, Onurdag FK, Banoglu E. 2011. Synthesis, antioxidant and antimicrobial evaluation of simple aromatic esters of ferulic acid. Arch. Pharm. Res. 34: 1251-1261. https://doi.org/10.1007/s12272-011-0803-y
  14. Farber BF, Wolff AG. 1993. Salicylic acid prevents the adherence of bacteria and yeast to silastic catheters. J. Biomed. Mater. Res. 27: 599-602. https://doi.org/10.1002/jbm.820270506
  15. Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d'Enfert C. 2004. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell 3: 536-545. https://doi.org/10.1128/EC.3.2.536-545.2004
  16. He M, Du M, Fan M, Bian Z. 2007. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 163: 137-143. https://doi.org/10.1007/s11046-007-0097-2
  17. Hemaiswarya S, Doble M. 2010. Synergistic interaction of phenylpropanoids with antibiotics against bacteria. J. Med. Microbiol. 59: 1469-1476. https://doi.org/10.1099/jmm.0.022426-0
  18. Hemaiswarya S, Soudaminikkutty R, Narasumani ML, Doble M. 2011. Phenylpropanoids inhibit protofilament formation of Escherichia coli cell division protein FtsZ. J. Med. Microbiol. 60: 1317-1325. https://doi.org/10.1099/jmm.0.030536-0
  19. Ivanauskas L, Jakstas V, Radusiene J, Lukosius A, Baranauskas A. 2008. Evaluation of phenolic acids and phenylpropanoids in the crude drugs. Medicina 44: 48.
  20. Kathiravan MK, Salake AB, Chothe AS, Dudhe PB, Watode RP, Mukta MS, et al. 2012. The biology and chemistry of antifungal agents: a review. Bioorg. Med. Chem. 20: 5678-5698. https://doi.org/10.1016/j.bmc.2012.04.045
  21. Khan A, Ahmad A, Akhtar F, Yousuf S, Xess I, Khan LA, et al. 2011. Induction of oxidative stress as a possible mechanism of the antifungal action of three phenylpropanoids. FEMS Yeast Res. 11: 114-122. https://doi.org/10.1111/j.1567-1364.2010.00697.x
  22. Khan MSA, Ahmad I. 2012. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. J. Antimicrob. Chemother. 67: 618-621 https://doi.org/10.1093/jac/dkr512
  23. Khodavandi A, Harmal NS, Alizadehd F, Scully OJ, Sidike SM, Othman F, et al. 2011. Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression. Phytomedicine 19: 56-63 https://doi.org/10.1016/j.phymed.2011.08.060
  24. Korkina LG. 2007. Phenylpropanoids as naturally occurring antioxidants: from plant defense to human health. Cell Mol. Biol. 53: 15-25.
  25. LaFleur MD, Kumamoto CA, Lewis K. 2006. Candida albicans biofilms produce antifungal tolerant persister cells. Antimicrob. Agents Chemother. 50: 3839-3846. https://doi.org/10.1128/AAC.00684-06
  26. Lee JH, Lee BK, Kim JH, Lee SH, Hong SK. 2009. Comparison of chemical compositions and antimicrobial activities of essential oils from three conifer trees; Pinus densiflora, Cryptomeria japonica, and Chamaecyparis obtusa. J. Microbiol. Biotechnol. 19: 391-396. https://doi.org/10.4014/jmb.0803.191
  27. Nickerson KW, Atkin AL, Hornby JM. 2006. Quorum sensing in dimorphic fungi: farnesol and beyond. Appl. Environ. Microbiol. 72: 3805-3813. https://doi.org/10.1128/AEM.02765-05
  28. Pauli A. 2006. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med. Res. Rev. 26: 223-268. https://doi.org/10.1002/med.20050
  29. Pfaller MA, Messer SA, Coffmann S. 1995. Comparison of visual and spectrophotometric method of MIC endpoint determinations by using microdilution methods to test five antifungal agents including the new triazole D0870. J. Clin. Microbiol. 33: 1094-1097.
  30. Raut JS, Karuppayil SM. 2014. Bioprospecting of plant essential oils for medicinal uses, pp. 59-76. In Fulekar MH, Pathak B, Kale RK (eds.). Environment and Sustainable Development. Springer, India.
  31. Raut JS, Shinde RB, Chauhan NM, Karuppayil SM. 2013. Terpenoids of plant origin inhibits morphogenesis, adhesion and biofilm formation by Candida albicans. Biofouling 29: 87-96 https://doi.org/10.1080/08927014.2012.749398
  32. Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Giannini MM. 2013. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol. 62: 10-24. https://doi.org/10.1099/jmm.0.045054-0
  33. Shinde RB, Raut JS, Karuppayil MS. 2012. Biofilm formation by Candida albicans on various prosthetic materials and its fluconazole sensitivity: a kinetic study. Mycoscience 53: 220-226 https://doi.org/10.1007/S10267-011-0155-Y
  34. Sudbery PE. 2011. Growth of Candida albicans hyphae. Nat. Rev. Microbiol. 9: 737-748. https://doi.org/10.1038/nrmicro2636
  35. Sung WS, Lee DG. 2010. Antifungal action of chlorogenic acid against pathogenic fungi, mediated by membrane disruption. Pure Appl. Chem. 82: 219-226.
  36. Zhao LX, Li DD, Hu DD, Hu GH, Yan L, Wang Y, et al. 2013. Effect of tetrandrine against Candida albicans biofilms. PLoS One 8: e79671. https://doi.org/10.1371/journal.pone.0079671

Cited by

  1. 7-hydroxycalamenene Effects on Secreted Aspartic Proteases Activity and Biofilm Formation of Candida spp. vol.12, pp.45, 2016, https://doi.org/10.4103/0973-1296.176022
  2. The Potential of Plant Phenolics in Prevention and Therapy of Skin Disorders vol.17, pp.2, 2014, https://doi.org/10.3390/ijms17020160
  3. Management of Candida biofilms: state of knowledge and new options for prevention and eradication vol.11, pp.2, 2016, https://doi.org/10.2217/fmb.15.139
  4. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against Candida albicans Biofilms vol.27, pp.4, 2014, https://doi.org/10.4014/jmb.1607.07072
  5. Candida Biofilms: Threats, Challenges, and Promising Strategies vol.5, pp.None, 2014, https://doi.org/10.3389/fmed.2018.00028
  6. Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents vol.9, pp.None, 2018, https://doi.org/10.3389/fmicb.2018.01351
  7. Transcriptomic and Genomic Approaches for Unravelling Candida albicans Biofilm Formation and Drug Resistance—An Update vol.9, pp.11, 2014, https://doi.org/10.3390/genes9110540
  8. Plant-Derived Products as Antibacterial and Antifungal Agents in Human Health Care vol.26, pp.29, 2014, https://doi.org/10.2174/0929867325666180831144344
  9. Sensitivity of the Candida albicans trehalose-deficient mutants tps1Δ and tps2Δ to amphotericin B and micafungin vol.68, pp.10, 2014, https://doi.org/10.1099/jmm.0.001053
  10. Anty-microbial, and anty-biofilm-forming properties of Origanum vulgare L. essential oils on Staphylococcus aureus and its antioxidant action vol.14, pp.2, 2014, https://doi.org/10.30970/sbi.1402.621
  11. Antimicrobial Activity of, and Cellular Pathways Targeted by, p-Anisaldehyde and Epigallocatechin Gallate in the Opportunistic Human Pathogen Pseudomonas aeruginosa vol.86, pp.4, 2014, https://doi.org/10.1128/aem.02482-19
  12. Virulence Characteristics of mecA -Positive Multidrug-Resistant Clinical Coagulase-Negative Staphylococci vol.8, pp.5, 2014, https://doi.org/10.3390/microorganisms8050659
  13. Anti-Fungal Efficacy and Mechanisms of Flavonoids vol.9, pp.2, 2020, https://doi.org/10.3390/antibiotics9020045
  14. Physical Properties of Vanillin Incorporated Self-Curing Orthodontic Polymethylmethacrylate Resin vol.853, pp.None, 2014, https://doi.org/10.4028/www.scientific.net/kem.853.46
  15. Phytochemical Composition and In Vitro Antimicrobial Activity of Essential Oils from the Lamiaceae Family against Streptococcus agalactiae and Candida albicans Biofilms vol.9, pp.9, 2014, https://doi.org/10.3390/antibiotics9090592
  16. Plant Preparations and Compounds with Activities against Biofilms Formed by Candida spp. vol.7, pp.5, 2021, https://doi.org/10.3390/jof7050360
  17. In Vitro Activity of Selected Phenolic Compounds against Planktonic and Biofilm Cells of Food-Contaminating Yeasts vol.10, pp.7, 2014, https://doi.org/10.3390/foods10071652
  18. Anti-Candidal Activity of the Parasitic Plant Orobanche crenata Forssk vol.10, pp.11, 2014, https://doi.org/10.3390/antibiotics10111373
  19. Plant active products and emerging interventions in water potabilisation: disinfection and multi-drug resistant pathogen treatment vol.7, pp.1, 2014, https://doi.org/10.1186/s40816-021-00258-4